Published in Am J Cardiol on July 01, 1978
Randomised controlled trial of physiological and ventricular pacing. Br Heart J (1983) 2.66
Carotid sinus syncope treated by pacing. Analysis of persistent symptoms and role of atrioventricular sequential pacing. Br Heart J (1982) 1.98
Pacemaker syndrome: an iatrogenic condition. Br Heart J (1992) 1.48
"Subclinical" pacemaker syndrome: a randomised study of symptom free patients with ventricular demand (VVI) pacemakers upgraded to dual chamber devices. Br Heart J (1992) 1.30
A comparison of symptoms and intra-arterial ambulatory blood pressure during long term dual chamber atrioventricular synchronous (DDD) and ventricular demand (VVI) pacing. Br Heart J (1987) 1.11
Benefits of dual chamber pacing in sick sinus syndrome. Br Heart J (1988) 1.02
Ambulatory blood pressure and assessment of pacemaker function. Br Heart J (1986) 0.87
Atrial natriuretic peptide in spontaneous tachycardias. Br Heart J (1987) 0.84
Artificial cardiac stimulation: a current view of physiologic pacemakers. Can Med Assoc J (1983) 0.78
The paradox of beta-adrenergic blockade in hypertension. Circulation (1968) 3.78
Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations. Am J Cardiol (1972) 3.37
Prevalence and characteristics of narghile smoking among university students in Syria. Int J Tuberc Lung Dis (2004) 2.38
Medical intelligence drug therapy: captopril. N Engl J Med (1982) 2.30
Converting enzyme inhibition with an orally active compound in hypertensive man. Hypertension (1980) 1.95
A biomarker approach to measuring human dietary exposure to certain phthalate diesters. Food Addit Contam (2001) 1.73
Cardiac hypertrophy in spontaneously hypertensive rats. Circ Res (1974) 1.64
Cloning and characterization of a novel cDNA that is IFN-gamma-induced in mouse peritoneal macrophages and encodes a putative GTP-binding protein. J Leukoc Biol (1995) 1.63
Report of the task force on blood pressure control in children. Pediatrics (1977) 1.60
Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications. N Engl J Med (1979) 1.49
The effects of percutaneous catheter ablation on preexisting permanent pacemakers. Pacing Clin Electrophysiol (1990) 1.46
Development of antinuclear antibodies during acebutolol therapy. Clin Pharmacol Ther (1979) 1.42
Assessment of parasympathetic control of heart rate by a noninvasive method. Am J Physiol (1984) 1.41
Idiopathic hypovolemia. Ann Intern Med (1986) 1.40
HIV/AIDS policies and sports: the National Football League. Med Sci Sports Exerc (1994) 1.38
Arterial pressure responses to discontinuing antihypertensive drugs. Circulation (1968) 1.37
Levels of di-(2-ethylhexyl)phthalate and total phthalate esters in milk, cream, butter and cheese. Food Addit Contam (1994) 1.33
The Cox-Maze procedure: the Cleveland Clinic experience. Semin Thorac Cardiovasc Surg (2000) 1.30
Haemodynamics of orally-active converting enzyme inhibitor (SQ 14225) in hypertensive patients. Clin Sci Mol Med (1978) 1.30
Orthostatic hypotension: mechanisms and management. Am Heart J (1975) 1.29
Cardiac hypertrophy and antihypertensive therapy. Cardiovasc Res (1977) 1.27
Left ventricular diastolic function in hypertension: relation to left ventricular mass and systolic function. J Am Coll Cardiol (1984) 1.22
Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril. Am J Med (1982) 1.19
Clonidine-suppression test: a useful aid in the diagnosis of pheochromocytoma. N Engl J Med (1981) 1.18
Long-term thiazide therapy in essential hypertension. Evidence for persistent alteration in plasma volume and renin activity. Circulation (1970) 1.18
The effects of nuclear magnetic resonance on patients with cardiac pacemakers. Radiology (1983) 1.18
Tilt test for investigating a neural component in hypertension. Its correlation with clinical characteristics. Circulation (1967) 1.17
Idiopathic orthostatic hypotension: circulatory dynamics in chronic autonomic insufficiency. Am J Cardiol (1974) 1.16
EMF genes regulate Arabidopsis inflorescence development. Plant Cell (1997) 1.15
Hyperdynamic beta-adrenergic circulatory state. Increased beta-receptor responsiveness. Arch Intern Med (1969) 1.14
Diuretic and diet treatment of hypertension. Arch Intern Med (1974) 1.13
Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy? Am J Cardiol (1979) 1.13
Plasma volume and chronic hypertension. Relationship to arterial pressure levels in different hypertensive diseases. Arch Intern Med (1970) 1.12
The changing clinical spectrum of primary aldosteronism. Am J Med (1983) 1.11
Dependence of arterial pressure on intravascular volume in treated hypertensive patients. N Engl J Med (1972) 1.11
Systemic arterial hypertension associated with cardiac surgery. Am J Cardiol (1980) 1.10
Effect of converting enzyme inhibitor (SQ14,225) on myocardial hypertrophy in spontaneously hypertensive rats. Hypertension (1980) 1.08
Vasodilating drugs: contrasting haemodynamic effects. Clin Sci Mol Med Suppl (1976) 1.06
Reversal of left ventricular hypertrophy in hypertensive patients treated with methyldopa. Lack of association with blood pressure control. Am J Cardiol (1982) 1.06
Clinical-physiological correlations in the development of hypertensive heart disease. Circulation (1971) 1.06
A UK retail survey of aflatoxins in herbs and spices and their fate during cooking. Food Addit Contam (1996) 1.06
Transient renal dysfunction during initial inhibition of converting enzyme in congestive heart failure. Br Heart J (1984) 1.04
Regression of left ventricular hypertrophy from systemic hypertension by enalapril. Am J Cardiol (1984) 1.03
Evaluation of migration models that might be used in support of regulations for food-contact plastics. Food Addit Contam (2005) 1.03
The multifactorial role of catecholamines in hypertensive cardiac hypertrophy. Eur Heart J (1982) 1.02
Plasma volume in men with essential hypertension. N Engl J Med (1968) 1.02
Spectral evidence for the cytochrome P450 nature of prostacyclin synthetase. Biochem Pharmacol (1981) 1.01
Chemical methods for the detection of lipid hydroperoxides. Methods Enzymol (1984) 1.01
Long-term control of congestive heart failure with captopril. Am J Cardiol (1982) 1.00
Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia. Am J Med (1982) 0.99
Physiological comparison of labile and essential hypertension. Circ Res (1970) 0.99
Captopril in congestive heart failure resistant to other vasodilators. Eur Heart J (1984) 0.99
Systemic hypertension following myocardial revascularization. Am Heart J (1973) 0.98
Antihypertensive drugs: clinical pharmacology and therapeutic use. Drugs (1977) 0.97
Re-examination of the hemodynamics of hypertension. Am J Med Sci (1969) 0.96
Investigations into the potential degradation of polycarbonate baby bottles during sterilization with consequent release of bisphenol A. Food Addit Contam (1997) 0.96
Determinants of left ventricular hypertrophy and function in hypertensive patients. An echocardiographic study. Am J Med (1983) 0.96
Long-term converting enzyme inhibition and sympathetic nerve function in hypertensive humans. Hypertension (1982) 0.95
Electrocardiographic changes reflecting left atrial abnormality in hypertension. Circulation (1966) 0.94
Automated cardiac output measurement by spatiotemporal integration of color Doppler data. In vitro and clinical validation. Circulation (1997) 0.94
Left atrial abnormality and ventricular preejection period in hypertension. Dis Chest (1969) 0.94
Liquid chromatographic determination of residual isocyanate monomers in plastics intended for food contact use. J AOAC Int (1995) 0.94
Cardiac output and distribution of blood volume in central and peripheral circulations in hypertensive and normotensive man. Br Heart J (1969) 0.94
Effects of aorto-coronary bypass on myocardial contractility. J Thorac Cardiovasc Surg (1973) 0.94
Dihydroergotamine in idiopathic orthostatic hypotension: short-term intramuscular and long-term oral therapy. Clin Pharmacol Ther (1981) 0.93
Beta-adrenergic blockade in diuretic-treated patients with essential hypertension. N Engl J Med (1975) 0.92
Plasma volume changes with long-term beta-adrenergic blockade. Am Heart J (1971) 0.92
Hemodynamic and volume changes associated with captopril. Hypertension (1980) 0.92
Coronary blood flow in left ventricular hypertrophy: a review of experimental data. Eur Heart J (1982) 0.92
Abnormal left ventricular relaxation in hypertensive patients. Clin Sci (Lond) (1980) 0.92
A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response. Am Heart J (1985) 0.91
Cardiac performance in rats with renal hypertension. Circ Res (1976) 0.91
Dietary exposure to chemical migrants from food contact materials: a probabilistic approach. Food Addit Contam (2005) 0.91
Similar effects of hydrochlorothiazide and spironolactone on plasma renin activity in essential hypertension. Cleve Clin Q (1972) 0.91
Resistant hypertension: diagnosis and management. Ann Intern Med (1978) 0.91
Effect of beta-receptor-blocking agents on cardiovascular structural changes in spontaneous and noradrenaline-induced hypertension in rats. Clin Sci (Lond) (1980) 0.91
A hemodynamic comparison of essential and renovascular hypertension. Cardiac output and total peripheral resistance: supine and tilted patients. Circulation (1967) 0.90
Renin, aldosterone and cardiac decompensation: studies with an oral converting enzyme inhibitor in heart failure. Am J Cardiol (1979) 0.90
On the mechanism of suppressed plasma-renin activity during beta-adrenergic blockade with propranolol. J Lab Clin Med (1974) 0.90
Regression of left ventricular hypertrophy by medical treatment: present status and possible implications. Am J Med (1983) 0.90